Tag: intellis
Medtronic announces results showing meaningful pain relief using DTM SCS endurance...
Medtronic has announced three-month results from an on-label, prospective, multicentre study showing meaningful pain relief using DTM SCS endurance therapy—a modified, lower-energy variation of the...
Intellis is now licensed in Canada
Medtronic has announced in a press release that it has received a licence from Health Canada for its Intellis platform, which includes the world's...
First patient enrolled in study to assess optimised spinal cord stimulation...
The first patient has been enrolled in the Vectors Post Market Clinical Study. The study will follow patients with chronic intractable pain who are...
Intellis platform receives CE mark for spinal cord and peripheral nerve...
Medtronic has received CE mark for the Intellis platform for both spinal cord stimulation (SCS) and peripheral nerve stimulation (PNS) as an aid in...
FDA approves Intellis platform for chronic pain
The US Food and Drug Administration has approved the Intellis spinal cord stimulation platform (Medtronic) for the management of certain types of chronic intractable...
